{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:01:21Z","timestamp":1791295281881,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,11,28]],"date-time":"2008-11-28T00:00:00Z","timestamp":1227830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Clin Pathol"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1186\/1472-6890-8-13","type":"journal-article","created":{"date-parts":[[2008,11,28]],"date-time":"2008-11-28T19:14:17Z","timestamp":1227899657000},"source":"Crossref","is-referenced-by-count":24,"title":["Immunophenotypic studies of monoclonal gammopathy of undetermined significance"],"prefix":"10.1186","volume":"8","author":[{"given":"Horatiu","family":"Olteanu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-You","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weina","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin J","family":"Karandikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,11,28]]},"reference":[{"issue":"8","key":"61_CR1","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1056\/NEJMoa01133202","volume":"346","author":"RA Kyle","year":"2002","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ: A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002, 346 (8): 564-569. 10.1056\/NEJMoa01133202.","journal-title":"N Engl J Med"},{"issue":"13","key":"61_CR2","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMoa054494","volume":"354","author":"RA Kyle","year":"2006","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, Dispenzieri A, Katzmann JA, Melton LJ: Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med. 2006, 354 (13): 1362-1369. 10.1056\/NEJMoa054494.","journal-title":"N Engl J Med"},{"issue":"6","key":"61_CR3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1365-2141.2006.06235.x","volume":"134","author":"RA Kyle","year":"2006","unstructured":"Kyle RA, Rajkumar SV: Monoclonal gammopathy of undetermined significance. Br J Haematol. 2006, 134 (6): 573-589. 10.1111\/j.1365-2141.2006.06235.x.","journal-title":"Br J Haematol"},{"issue":"5","key":"61_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.blre.2007.01.002","volume":"21","author":"SV Rajkumar","year":"2007","unstructured":"Rajkumar SV, Lacy MQ, Kyle RA: Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. Blood Rev. 2007, 21 (5): 255-265. 10.1016\/j.blre.2007.01.002.","journal-title":"Blood Rev"},{"key":"61_CR5","first-page":"142","volume-title":"Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues","author":"TM Grogan","year":"2001","unstructured":"Grogan TM, van Camp B, Kyle RA, Mueller-Hermelink HK, Harris NL: Plasma cell neoplasms. Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues. Edited by: Jaffe ES, Harris NL, Stein H, Vardiman JW. 2001, Lyon: IARC, 142-156."},{"issue":"13","key":"61_CR6","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.1182\/blood-2003-01-0016","volume":"102","author":"FE Davies","year":"2003","unstructured":"Davies FE, Dring AM, Li C, Rawstron AC, Shammas MA, O'Connor SM, Fenton JA, Hideshima T, Chauhan D, Tai IT: Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis. Blood. 2003, 102 (13): 4504-4511. 10.1182\/blood-2003-01-0016.","journal-title":"Blood"},{"issue":"3","key":"61_CR7","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/sj.leu.2403647","volume":"19","author":"M Perez-Andres","year":"2005","unstructured":"Perez-Andres M, Almeida J, Martin-Ayuso M, Moro MJ, Martin-Nunez G, Galende J, Borrego D, Rodriguez MJ, Ortega F, Hernandez J: Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment. Leukemia. 2005, 19 (3): 449-455. 10.1038\/sj.leu.2403647.","journal-title":"Leukemia"},{"issue":"1","key":"61_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1532\/IJH97.05112","volume":"83","author":"K Otsuyama","year":"2006","unstructured":"Otsuyama K, Asaoku H, Kawano MM: An increase in MPC-1- and MPC-1-CD45+ immature myeloma cells in the progressive states of bone marrow plasmacytosis: the revised phenotypic classification of monoclonal marrow plasmacytosis (MOMP-2005). Int J Hematol. 2006, 83 (1): 39-43. 10.1532\/IJH97.05112.","journal-title":"Int J Hematol"},{"issue":"13","key":"61_CR9","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1182\/blood-2006-06-029355","volume":"108","author":"J Moreaux","year":"2006","unstructured":"Moreaux J, Hose D, Reme T, Jourdan E, Hundemer M, Legouffe E, Moine P, Bourin P, Moos M, Corre J: CD200 is a new prognostic factor in multiple myeloma. Blood. 2006, 108 (13): 4194-4197. 10.1182\/blood-2006-06-029355.","journal-title":"Blood"},{"issue":"6","key":"61_CR10","first-page":"1655","volume":"152","author":"M Ocqueteau","year":"1998","unstructured":"Ocqueteau M, Orfao A, Almeida J, Blade J, Gonzalez M, Garcia-Sanz R, Lopez-Berges C, Moro MJ, Hernandez J, Escribano L: Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma. Am J Pathol. 1998, 152 (6): 1655-1665.","journal-title":"Am J Pathol"},{"issue":"6","key":"61_CR11","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1309\/VWXARAAG9DAPQ31Y","volume":"126","author":"S Kobayashi","year":"2006","unstructured":"Kobayashi S, Hyo R, Amitani Y, Tanaka M, Hashimoto C, Sakai R, Tamura T, Motomura S, Maruta A: Four-color flow cytometric analysis of myeloma plasma cells. Am J Clin Pathol. 2006, 126 (6): 908-915. 10.1309\/VWXARAAG9DAPQ31Y.","journal-title":"Am J Clin Pathol"},{"issue":"9","key":"61_CR12","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1182\/blood-2001-12-0297","volume":"100","author":"AC Rawstron","year":"2002","unstructured":"Rawstron AC, Davies FE, DasGupta R, Ashcroft AJ, Patmore R, Drayson MT, Owen RG, Jack AS, Child JA, Morgan GJ: Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation. Blood. 2002, 100 (9): 3095-3100. 10.1182\/blood-2001-12-0297.","journal-title":"Blood"},{"key":"61_CR13","doi-asserted-by":"crossref","unstructured":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003, 121 (5): 749-757. 10.1046\/j.1365-2141.2003.04355.x.","DOI":"10.1046\/j.1365-2141.2003.04355.x"},{"issue":"2","key":"61_CR14","first-page":"119","volume":"47","author":"J Almeida","year":"1999","unstructured":"Almeida J, Orfao A, Mateo G, Ocqueteau M, Garcia-Sanz R, Moro MJ, Hernandez J, Ortega F, Borrego D, Barez A: Immunophenotypic and DNA content characteristics of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance. Pathol Biol (Paris). 1999, 47 (2): 119-127.","journal-title":"Pathol Biol (Paris)"},{"issue":"8","key":"61_CR15","first-page":"837","volume":"86","author":"O Sezer","year":"2001","unstructured":"Sezer O, Heider U, Zavrski I, Possinger K: Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells. Haematologica. 2001, 86 (8): 837-843.","journal-title":"Haematologica"},{"issue":"1","key":"61_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1046\/j.1365-2141.1997.72653.x","volume":"97","author":"AC Rawstron","year":"1997","unstructured":"Rawstron AC, Owen RG, Davies FE, Johnson RJ, Jones RA, Richards SJ, Evans PA, Child JA, Smith GM, Jack AS: Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage. Br J Haematol. 1997, 97 (1): 46-55. 10.1046\/j.1365-2141.1997.72653.x.","journal-title":"Br J Haematol"},{"issue":"10","key":"61_CR17","first-page":"1365","volume":"90","author":"ME Sarasquete","year":"2005","unstructured":"Sarasquete ME, Garcia-Sanz R, Gonzalez D, Martinez J, Mateo G, Martinez P, Ribera JM, Hernandez JM, Lahuerta JJ, Orfao A: Minimal residual disease monitoring in multiple myeloma: a comparison between allelic-specific oligonucleotide real-time quantitative polymerase chain reaction and flow cytometry. Haematologica. 2005, 90 (10): 1365-1372.","journal-title":"Haematologica"},{"issue":"10","key":"61_CR18","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1182\/blood.V81.10.2658.2658","volume":"81","author":"H Harada","year":"1993","unstructured":"Harada H, Kawano MM, Huang N, Harada Y, Iwato K, Tanabe O, Tanaka H, Sakai A, Asaoku H, Kuramoto A: Phenotypic difference of normal plasma cells from mature myeloma cells. Blood. 1993, 81 (10): 2658-2663.","journal-title":"Blood"},{"issue":"4","key":"61_CR19","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1309\/74R4TB90BUWH27JX","volume":"121","author":"P Lin","year":"2004","unstructured":"Lin P, Owens R, Tricot G, Wilson CS: Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma. Am J Clin Pathol. 2004, 121 (4): 482-488. 10.1309\/74R4TB90BUWH27JX.","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"61_CR20","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1006\/bcmd.2000.0342","volume":"26","author":"M Lima","year":"2000","unstructured":"Lima M, Teixeira Mdos A, Fonseca S, Goncalves C, Guerra M, Queiros ML, Santos AH, Coutinho A, Pinho L, Marques L: Immunophenotypic aberrations, DNA content, and cell cycle analysis of plasma cells in patients with myeloma and monoclonal gammopathies. Blood Cells Mol Dis. 2000, 26 (6): 634-645. 10.1006\/bcmd.2000.0342.","journal-title":"Blood Cells Mol Dis"},{"issue":"4","key":"61_CR21","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0002-9440(10)62556-4","volume":"160","author":"SA Ely","year":"2002","unstructured":"Ely SA, Knowles DM: Expression of CD56\/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation. Am J Pathol. 2002, 160 (4): 1293-1299.","journal-title":"Am J Pathol"},{"issue":"3","key":"61_CR22","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3324\/haematol.11080","volume":"93","author":"AC Rawstron","year":"2008","unstructured":"Rawstron AC, Orfao A, Beksac M, Bezdickova L, Brooimans RA, Bumbea H, Dalva K, Fuhler G, Gratama J, Hose D: Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders. Haematologica. 2008, 93 (3): 431-438. 10.3324\/haematol.11080.","journal-title":"Haematologica"},{"issue":"2","key":"61_CR23","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1309\/5EL22BH45PHUPM8P","volume":"127","author":"AC Seegmiller","year":"2007","unstructured":"Seegmiller AC, Xu Y, McKenna RW, Karandikar NJ: Immunophenotypic differentiation between neoplastic plasma cells in mature B-cell lymphoma vs plasma cell myeloma. Am J Clin Pathol. 2007, 127 (2): 176-181. 10.1309\/5EL22BH45PHUPM8P.","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"61_CR24","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.leukres.2005.04.009","volume":"29","author":"N Niitsu","year":"2005","unstructured":"Niitsu N, Kohri M, Hayama M, Nakamine H, Nakamura N, Bessho M, Higashihara M: Primary pulmonary plasmacytoma involving bilateral lungs and marked hypergammaglobulinemia: differentiation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Leuk Res. 2005, 29 (11): 1361-1364. 10.1016\/j.leukres.2005.04.009.","journal-title":"Leuk Res"},{"issue":"1","key":"61_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1046\/j.1365-2141.1996.d01-1784.x","volume":"94","author":"D Joshua","year":"1996","unstructured":"Joshua D, Petersen A, Brown R, Pope B, Snowdon L, Gibson J: The labelling index of primitive plasma cells determines the clinical behaviour of patients with myelomatosis. Br J Haematol. 1996, 94 (1): 76-81. 10.1046\/j.1365-2141.1996.d01-1784.x.","journal-title":"Br J Haematol"},{"key":"61_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1034\/j.1600-065X.2003.00039.x","volume":"194","author":"R Bataille","year":"2003","unstructured":"Bataille R, Robillard N, Pellat-Deceunynck C, Amiot M: A cellular model for myeloma cell growth and maturation based on an intraclonal CD45 hierarchy. Immunol Rev. 2003, 194: 105-111. 10.1034\/j.1600-065X.2003.00039.x.","journal-title":"Immunol Rev"},{"issue":"7","key":"61_CR27","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1182\/blood-2007-05-088443","volume":"110","author":"E Perez-Persona","year":"2007","unstructured":"Perez-Persona E, Vidriales MB, Mateo G, Garcia-Sanz R, Mateos MV, de Coca AG, Galende J, Martin-Nunez G, Alonso JM, de Las Heras N: New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells. Blood. 2007, 110 (7): 2586-2592. 10.1182\/blood-2007-05-088443.","journal-title":"Blood"},{"issue":"11","key":"61_CR28","first-page":"36A","volume":"102","author":"AC Rawstron","year":"2003","unstructured":"Rawstron AC, Fenton JA, Gonzalez D, Dring AM, O'Connor SM, Owen RG, Richards SJ, Jack AS, Davies FE, Child JA: High-Risk MGUS: Identification by Immunophenotype, Karyotype and Clonal Homogeneity. Blood. 2003, 102 (11): 36A-","journal-title":"Blood"},{"issue":"1","key":"61_CR29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V91.1.3","volume":"91","author":"M Hallek","year":"1998","unstructured":"Hallek M, Bergsagel PL, Anderson KC: Multiple myeloma: increasing evidence for a multistep transformation process. Blood. 1998, 91 (1): 3-21.","journal-title":"Blood"},{"issue":"2","key":"61_CR30","first-page":"89","volume":"47","author":"FK Stevenson","year":"1999","unstructured":"Stevenson FK, Sahota SS: B cell maturation in relation to multiple myeloma. Pathol Biol (Paris). 1999, 47 (2): 89-97.","journal-title":"Pathol Biol (Paris)"},{"issue":"3","key":"61_CR31","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrc746","volume":"2","author":"WM Kuehl","year":"2002","unstructured":"Kuehl WM, Bergsagel PL: Multiple myeloma: evolving genetic events and host interactions. Nat Rev Cancer. 2002, 2 (3): 175-187. 10.1038\/nrc746.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"61_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/hon.688","volume":"20","author":"JA Fenton","year":"2002","unstructured":"Fenton JA, Pratt G, Rawstron AC, Morgan GJ: Isotype class switching and the pathogenesis of multiple myeloma. Hematol Oncol. 2002, 20 (2): 75-85. 10.1002\/hon.688.","journal-title":"Hematol Oncol"},{"issue":"3","key":"61_CR33","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","volume":"106","author":"SV Rajkumar","year":"2005","unstructured":"Rajkumar SV, Kyle RA, Therneau TM, Melton LJ, Bradwell AR, Clark RJ, Larson DR, Plevak MF, Dispenzieri A, Katzmann JA: Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood. 2005, 106 (3): 812-817. 10.1182\/blood-2005-03-1038.","journal-title":"Blood"}],"container-title":["BMC Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6890-8-13\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6890-8-13.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6890-8-13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6890-8-13.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T05:23:19Z","timestamp":1589260999000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcclinpathol.biomedcentral.com\/articles\/10.1186\/1472-6890-8-13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,28]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["61"],"URL":"https:\/\/doi.org\/10.1186\/1472-6890-8-13","relation":{},"ISSN":["1472-6890"],"issn-type":[{"value":"1472-6890","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,28]]},"article-number":"13"}}